About us
The independent Institute for Quality and Efficiency in Health Care (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, IQWiG) examines the benefits and harms of medical interventions for patients.
Projects
Participation
Events
Press
Contact
Breadcrumbs
Introduction
Prof. Dr. Ralf Bender
Pooling of studies with different characteristics
Dr. Volker Vervölgyi
IQWiG's biometric approach to heterogeneity - current status and outlook
Dr. Guido Skipka
Measures on heterogeneity in meta-analyses - critical discussion
Dr. Gerta Rücker (University Clinic Freiburg)
Examination and handling of heteregeneity in benefit assessments - an outline of the problem
Dr. Sandra Janatzek (Medical Advisory Service of the German Social Health Insurance, Essen)
Meta-analysis of rare adverse drug effects from heterogeneous clinical trials
Dr. Ekkehard Glimm (Novartis Basel)
Discussion
Prof. Dr. Armin Koch (Medical School Hannover)
